Trials / Completed
CompletedNCT04705168
Study of the Nevisense Device to Assess Atypical Skin Lesions
Performance of Nevisense Electrical Impedance Spectroscopy in Patients With Multiple Nevi and Large Acquired Nevi (LAN)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out whether the Nevisense device can provide useful information about atypical moles to complement the usual assessments done during routine screening for melanoma. Assessing particpants' moles with the Nevisense device may help improve screening methods for the early detection of melanoma in people with atypical mole syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Nevisense electrical impedance spectroscopy | Each participants will undergo Nevisense electrical impedance spectroscopy in order to characterize the electrical impedance spectroscopy scores of nevi in patients with ≥ 100 nevi on the entire cutaneous surface and at least three large acquired nevi (LAN) \> 5 mm in diameter |
Timeline
- Start date
- 2021-01-08
- Primary completion
- 2025-11-18
- Completion
- 2025-11-18
- First posted
- 2021-01-12
- Last updated
- 2025-11-20
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04705168. Inclusion in this directory is not an endorsement.